PATENT CLAIM ANALYSIS

Application Number: 16263518
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-12
Patent Classification: ["514", "249000"]

Abstract:
The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as prostaglandin EP4 receptor antagonists, and are useful in the treatment or alleviation of pain and inflammation and other inflammation-associated disorders, such as arthritis, treating or preventing disorders or medical conditions selected from pain, inflammatory diseases and the like. Also described herein are methods of treating pain by administering the compounds of the invention, which are EP4 receptor antagonists.

Claim (Index 14):
The compound of  claim 3 , or a veterinary or pharmaceutically acceptable salt thereof, wherein L is \u2014CH 2 CH 2 \u2014.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16100315', '15211062', '16123251', '14995547', '11078898']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.829742431638064
- 35 USC 102 Novelty (BERT): 0.5571277238071358
- Combined Prediction Score: 0.8024809608549712
- Mean Citation Score: 368.446638
- Max Citation Score: 448.91812
- Similarity Product: 319.80344413533925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test